Officials at Musk-led DOGE were given access to the inner workings of the Centers for Medicare and Medicaid Services (CMS), ...

Elon Musk's DOGE is reviewing Medicare and Medicaid for waste and fraud, gaining access to key HHS data systems. Follow ...

Over the last few weeks, we’ve been fielding numerous questions regarding the Medicare Part D Prescription Drug plans that ...

When Congress created the Part D benefit for Medicare beneficiaries, it also required group health plan sponsors and certain ...

The company reported a Q4 adjusted diluted EPS of $0.80 and full-year 2024 adjusted diluted EPS of $7.17, exceeding prior guidance. Revenue guidance for 2025 was raised by $4B to a range of $158B to ...

President Donald Trump was handed an opportunity to "save" Medicare Advantage after the Biden administration's final proposal ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Declining enrollment, fewer plan offerings, and persistently higher premiums are raising concerns about the stability and ...

Under the Inflation Reduction Act of 2022 (IRA), signed into law by President Joe Biden in August 2022, the federal government capped prescription drug cost inflation and is negotiating drug ...

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

Protection of access to care for Medicare beneficiaries, particularly in rural and underserved areas, has drawn a proposal from a North Carolina congressman in part combatting ...